The Division of Cancer Treatment and Diagnosis (DCTD) works alongside academia and industry professionals to improve cancer care. Their mission focuses on creating innovative diagnostics and therapies that enhance patient prognosis and quality of life. DCTD's initiatives range from drug discovery to late-stage clinical trials. One key strategy is the modernization of the NCI-60 Human Tumor Cell Lines Screen, used for identifying potential drug candidates and understanding the molecular complexities of a tumor. With their new discoveries and upcoming treatments, DCTD offers cancer patients a brighter future. They also encourage cooperation through regular meetings and funding opportunities. Therefore, DCTD fosters a relationship between academic, industrial, and medical professionals, modernizes essential tools for drug discovery, produces novel treatments, and promotes a collaborative environment for cancer research.
Full article here: https://medium.com/@lawsuithelpdesk/unmasking-the-future-of-cancer-treatment-innovative-therapies-breakthrough-discoveries-and-the-e4e6281ea12c